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Abnormal nephron development associated with a frameshift Maturity-onset diabetes of the young (MODY) is a
mutation in the transcription factor hepatocyte nuclear factor-1b. form of non-insulin-dependent diabetes mellitus charac-
Background. The transcription factor hepatocyte nuclear
terized by autosomal dominant inheritance and a youngfactor (HNF)-1b functions as a homodimer or as a heterodimer
age of onset, usually diagnosed before the age of 25 [1, 2].with the structurally related protein HNF-1a. Both are ex-
pressed sequentially in rat kidney development, with HNF-1b MODY is associated with heterozygous mutations in
being detected from the earliest inductory phases. HNF-1b the genes encoding the glycolytic enzyme glucokinasegene mutations are associated with a unique disorder character-
(MODY2) located on chromosome 7p [3, 4] and the tran-ized by maturity-onset diabetes of the young (MODY) and early-
onset and progressive nondiabetic renal dysfunction, which scription factors hepatocyte nuclear factor (HNF)-1a
may lead to chronic renal failure. (MODY3) chromosome 12q [5], HNF-4a (MODY1)
Methods. The HNF-1b gene was screened for mutations in chromosome 20q [6], insulin promoter factor (IPF)-1six subjects with early-onset diabetes and a history of renal
(MODY4) chromosome 13q [7], and HNF-1b (MODY5)dysfunction in the subjects or their families.
Results. A novel frameshift mutation in exon 4 of the HNF- chromosome 17q [8, 9].
1b gene and a deletion of CCTCT at codons 328 to 329 were Hepatocyte nuclear factor-1a and HNF-1b are struc-
detected in one subject. She was diagnosed as diabetic at the
turally related members of the homeodomain-containingage of 21 in her second pregnancy. Glucose tolerance rapidly
superfamily of transcription factors [10, 11]. They func-deteriorated over 18 months as a result of b-cell dysfunction.
The HNF-1b mutation arose de novo on a paternal chromo- tion as homodimers or heterodimers. They play a role
some and cosegregated with renal abnormalities in her family. in the tissue-specific regulation of gene expression in aThe proband had bilateral small cysts in normal-sized kidneys
number of tissues, including liver, kidney, intestine, andand a reduced creatinine clearance of 66 mL/min (NR 80–120).
Her first pregnancy was terminated at 17 weeks following an pancreatic islets, and are involved in the embryonic de-
ultrasound diagnosis of bilateral, nonfunctioning cystic kidneys. velopment of these organs, all of which have specialized
Her first-born child had a small multicystic, dysplastic right polarized epithelia [12].kidney and a dysplastic left kidney with a reduced creatinine
Two families have been described with HNF-1b muta-clearance (40 mL/min per 1.73 m2). Histologic examination of
the large (5.8 vs. 1.4 g), polycystic fetal kidneys showed no tions, and both have MODY and severe nondiabetic
normal nephrogenesis. renal dysfunction [8, 9]. It has not been established
Conclusions. These studies indicate that HNF-1b plays a cen-
whether the diabetes in these families principally resultstral role in normal kidney development and pancreatic b-cell
function, and suggest that one mechanism by which HNF-1b from b-cell dysfunction or insulin resistance, although
gene mutations may cause renal dysfunction are by their effects the work on HNF-1a mutations [13, 14] and other MODY
on nephron development.
subjects [1] suggests that b-cell dysfunction is likely. The
renal dysfunction can manifest as renal cysts, proteinuria,
1 See Editorial by Woolf, p. 1202 and chronic renal failure. The reasons for this diverse
Key words: cystic kidney, diabetes mellitus, genetics, transcription fac- phenotype are unclear, but may reflect the nature oftors, embryology, nephrogenesis.
the specific mutation found in each family, as well as
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Table 1. Subjects
Age at Duration
Family diagnosis of diabetes Other
proband of diabetes years Treatment complications Renal disease Family history of diabetes and renal disease
BDA206 25 0.67 Diet None Sister-diabetes 24 y
Mother-diabetes 23 y, retinopathy, nephropathy,
Charcot joint
Maternal grandmother-diabetes 40 y, retinopathy,
neuropathy, renal failure
BDA237 27 9 Gliclazide Retinopathy Nephrotic Father-diabetes 53 y
Metformin syndrome
BDA244 28 1 Metformin Proteinuria Father-diabetes 24 y, renal failure, renal transplant,
retinopathy
Brother-diabetes 30 y, nephropathy, retinopathy
Mother-diabetes
Paternal grandfather 1 3 siblings-diabetes
BDA247 20 9 Diet Adult polycystic Sister-diabetes 16 y, ADPKD
kidney disease Brother-diabetes 23 y, normal renal ultrasound
(ADPKD) Father-diabetes 55 y, cystic kidneys
Paternal uncle-diabetes 18 y
BDA253 12 19 Insulin Retinopathy Nephropathy Sister-nephropathy, retinopathy
BDA250 21 1.5 Insulin Renal cysts Daughter-termination at 17 weeks gestation with
cystic kidneys
Son-cystic right kidney, dysplastic left kidney
HNF-1b gene mutations is uncertain. Studies of the screened for HNF-1b gene mutations. The study was
expression of HNF-1b and HNF-1a mRNA during rat approved by the local ethics committee, and informed
embryogenesis suggest that HNF-1b is important from consent was obtained from each subject.
the earliest inductory phases of kidney development.
Mutation analysis of the hepatocyte nuclearHNF-1a appears later in the postinductory phase in cells
factor-1b genecommitted to tubular differentiation [12].
Although HNF-1a acts as a heterodimer with HNF-1b Genomic DNA was extracted from peripheral lym-
and causes diabetes, it is associated with different renal phocytes using a Nucleon DNA extraction kit (Scotlab,
manifestations. Human subjects with HNF-1a mutations Coatbridge, UK). Sections of paraffin-embedded lung
have defects in the renal resorption of glucose, phos- and heart tissue from the fetus were treated with xylene
phate, and amino acids [abstract, Velho et al, Diabeto- to remove the paraffin. The xylene was removed by wash-
logia 41(Suppl 1):A108, 1998] [15]. Renal dysfunction is ing twice with a 1:1 mix of xylene:ethanol and then twice
also a feature of the HNF-1a knockout mice. Homozy- with absolute ethanol. DNA was then extracted using
gous null animals exhibit a severe Fanconi-like syndrome a Qiagen QIAamp Tissue Kit (http://www.qiagen.com;
with polyuria (85% body wt per day), glucosuria, gener- catalog number 29304) according to the manufacturer’s
alized aminoaciduria, and phosphaturia caused by renal instructions.
proximal tubular dysfunction [16]. In addition, patients The entire promoter and coding regions of the nine
with HNF-1a mutations may develop microalbuminuria, exons and the intron-exon boundaries of the HNF-1b
macroalbuminuria, and renal failure as features of dia- gene were amplified by polymerase chain reaction (PCR)
betic nephropathy [17, 18]. The glycemic control is the
using genomic DNA from a single proband and sequence-best predictor of their development [18], as these are a
specific primers (http://www.diabetes.org). PCR was per-microvascular complication of hyperglycemia rather
formed in a 25 mL volume containing 10 mmol/L Tris-than a direct result of the mutation.
HCl, pH 8.3, 50 mmol/L KCl, 1 to 1.5 mmol/L MgCl2,Here we describe a third family with early-onset diabe-
200 mmol/L dNTPs, 2.5 pmol each primer, 0.25 U Ampli-tes and renal dysfunction, and present evidence sug-
taq Gold Taq polymerase (Perkin-Elmer, Warrington,gesting that HNF-1b plays an important role in nephron
UK), and 100 ng DNA. The cycling conditions were 15formation in humans.
minutes at 958C followed by 35 cycles consisting of one
minute at 948C, one minute at 608C, and two minutes at
METHODS 728C.
Subjects Polymerase chain reaction products were purified us-
ing a QIAquick column (Qiagen, Crawley, UK), and bothThe study population consisted of members of six un-
strands were sequenced using a BigDye Terminator Cy-related families with young-onset diabetes and renal dys-
function (Table 1). The probands in these families were cle Sequencing kit (Perkin-Elmer Applied Biosystems)
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according to the manufacturer’s recommendations. Re- binding protein was measured by an enzyme-linked im-
munosorbent assay (ELISA) kit.actions were analyzed on an ABI Prisme 377 DNA
Sequencer (Perkin-Elmer Applied Biosystems).
Radiological investigations
Renal ultrasound scans were performed. A micturat-Microsatellite analysis
ing cystogram and MAGIII renogram were performedTo haplotype the family with the HNF-1b frameshift
in one pediatric subject.mutation, neighboring microsatellites were analyzed.
The tightly linked microsatellites D17S1788, D17S927,
RESULTSand D17S800 were amplified using fluorescently labeled
primers in a 10 mL PCR reaction (mix as described pre- Identification of a frameshift mutation in the
viously in this article) with cycling conditions as de- hepatocyte nuclear factor-1b gene
scribed previously in this article except that the annealing A novel frameshift mutation in exon 4 of the HNF-
temperature was 558C. PCR products analyzed using an 1b gene was identified in one proband (BDA250). The
ABI Prisme 377 DNA Sequencer (Perkin-Elmer Applied five bp deletion (CCTCT) at codons 328 to 329 (mutation
Biosystems) and the software program Genotypere. designated P328L329fsdelCCTCT) causes a frameshift
(Fig. 1) that is predicted to result in a protein of 356
Clinical studies amino acids with amino acids 1 to 327 of the wild type
and an additional 29 amino acids from the shifted readingGlucose tolerance, insulin secretion, and b-cell func-
frame. The mutant protein retains the NH2-dimerizationtion. A standard 75 g oral glucose tolerance test (OGTT)
domain and the bipartite DNA-binding region, whichwas given after a 12-hour overnight fast during which
consists of a POU-like element and homeodomain, buttime insulin treatment was discontinued. Blood samples
the majority of the transcription activation domain (en-for glucose and insulin were drawn at 0, 30, 60, 90, and
coded by amino acids 291 to 532) is absent. This mutation120 minutes. Baseline fasting measurements of proinsu-
was also present in the female fetus that was therapeuti-lin and C-peptide were measured, and blood was taken to
cally aborted at 17 weeks and in the proband’s son (Fig. 2).measure islet cell antibodies. The results were compared
Neither of the proband’s unaffected parents carried the
with 23 individuals (13 women) with normal glucose tol- mutation. Haplotype analysis using microsatellite markers
erance and a body mass index of less than 25 kg/m2 gave results consistent with the parental relationships,
(mean 6 SD 22.3 6 2.2) aged 40.5 6 10.9 years. To demonstrating that the mutation had occurred spontane-
assess b-cell function, the 30-minute insulin/glucose in- ously on the paternal chromosome (Fig. 2). The mutation
cremental ratio was used and compared with the nor- was not present in 50 normal chromosomes analyzed by
moglycemic control subjects [19]. sequencing. No other mutations were found in the coding
Biochemical tests of renal function. Blood samples region or promoter in the other five probands.
were taken for the measurement of serum sodium, potas-
Clinical characteristicssium, urea, creatinine, calcium, cholesterol, and intact
molecule parathyroid hormone (PTH). A 24-hour urine The proband (II-2) underwent termination of preg-
nancy at 17 weeks following ultrasound diagnosis of bi-collection was obtained to measure creatinine clearance
lateral enlarged cystic kidneys in the fetus (III-1). At 36and protein excretion. A separate urine sample was ana-
weeks into her second pregnancy, at the age of 21, shelyzed for retinol-binding protein. In III-2, creatinine
developed glycosuria, and an OGTT [fasting plasma glu-clearance was calculated from the surface area [20].
cose (fpg) 6.4 mmol/L and a 2 h glucose at 15.7 mmol/L]
confirmed diabetes. Despite an appropriate diet, hyper-Assays
glycemia persisted, and she required insulin treatment.Sodium, potassium, urea, creatinine, calcium, choles-
There was no family history of diabetes. Eighteen months
terol, and glucose were measured using a Vitros analyzer.
after her pregnancy, insulin treatment was discontinued
PTH was measured with a DiaSorin immunoradiometric for 24 hours, and the OGTT was repeated (Fig. 3); this
assay kit. Insulin was measured with an immunoenzymo- showed a worsening of glucose tolerance (fpg 9.7 mmol/L,
metric assay specific for insulin (Lifescreen, UK). Proin- 2 h at 23.8 mmol/L). At this time, she was normotensive
sulin (total and intact) and C peptide were measured (BP 100/60 mm Hg) and not overweight, and the body
with immunoenzymometric assays (Dako, UK). Islet cell mass index (BMI) was 20.5 kg/m2.
antibodies were measured with a binding site indirect Her second pregnancy resulted in a male infant (III-2)
immunofluorescence test on monkey pancreas. born at 39 weeks gestation who on antenatal ultrasound
Urine creatinine and protein measurements were scanning at 18 weeks had been shown to have a multicys-
tic right kidney.made on a Bayer Technicon opeRA analyzer. Retinol-
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Fig. 1. Heterozygous P328L329fsdelCCTCT hepatocyte nuclear factor-1b (HNF-1b) gene mutation in exon 4 and normal control sequence.
Biochemical tests of renal function inappropriately low and hence inadequate (Fig. 3). Fur-
ther evidence of b-cell dysfunction was shown by the 30-The results of these tests on II-2 and III-2 are shown
minute insulin/glucose incremental ratio being greatlyin Table 2. Both II-2 and III-2 have a degree of renal
reduced at 5.0 3 1026 (control 2 SD, range 34.1 to 215.8 3impairment with creatinine clearances of 66 mL/min and
1026). Fasting intact proinsulin was ,1 pmol/L (control40 mL/min per 1.73 m2, respectively. A retinol-binding
1.68 6 2 SD, range ,1 to 4.6), fasting total proinsulinprotein ratio of 1.3 g/mmol creatinine shows no evidence
9.3 pmol/L (control 3.6 6 2 SD, range 1.3 to 9.9) andfor proximal renal tubular impairment of protein absorp-
fasting C peptide 536 pmol/L (control 293 6 2 SD, rangetion. III-2 has an elevated PTH at 6.9 pmol/L and an
111 to 769). Islet cell antibodies were negative.elevated serum calcium at 2.57 mmol/L.
Postmortem and histologic findings on fetus III-1Radiologic investigations
The 17-week female fetus was normal sized by footUltrasound examination of II-2 showed three small (1
length, with a protuberant abdomen (Fig. 5). The kidneysto 2 cm) cysts in the kidneys, which were of normal size.
had reniform outline, but were greatly enlarged (to-On ultrasound III-2 had a small, multicystic dysplastic
gether 5.8 g vs. 1.4 g expected for body wt). Multipleright kidney and a dysplastic left kidney showing loss of
round cysts, up to 0.3 cm in diameter, occupied the entirecorticomedullary differentiation and minor distention of
renal parenchyma. No longitudinal cysts were seen inthe collecting system toward the upper pole, which was
the cortex. Corticomedullary differentiation was not ap-not thought to be significant (Fig. 4). There was no evi-
parent. The pelvicalyceal system, ureters, and urinarydence of vesicoureteric reflux on a micturating cystogram.
bladder were present but small. There was no atresia ofThere was no outflow obstruction from the left kidney
the ureters and no obstructive lesion of the urinary tract.and nonfunction of the right kidney on a MAG III reno-
There were no macroscopic features of the clinical syn-gram.
dromes that can be associated with cystic kidneys; spe-
Assessment of b-cell function and insulin sensitivity cifically, there was no encephalocoele, no polydactyly,
and no macroscopic hepatic fibrosis [21–23].Insulin secretion during an oral OGTT was similar to
Histologic examination of the kidneys showed nothat in normoglycemic control subjects, despite marked
hyperglycemia, thus showing that insulin secretion was normal nephrogenesis. The normal renal parenchyma
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Fig. 2. Pedigree of family with the P328L329-
fsdelCCTCT mutation in the HNF-1b gene. Ro-
man numerals on the left of the figure indicate
generation number, and numbers below the
symbol indicate individual numbers within that
generation. The proband is indicated by an
arrow. Subjects with diabetes and/or renal mani-
festations are shaded with the details summa-
rized in the text beneath. The HNF-1b genotype
of each individual tested is indicated: N, normal;
M, P328L329fsdelCCTCT. The haplotypes de-
rived from microsatellites D17S1788, D17S927,
and D17S800 are shown.
was almost entirely replaced by round cysts (Fig. 6). the diabetes results from b-cell dysfunction and that the
Occasional cystic glomeruli and primitive tubules were cystic renal disease in the fetus shows no normal nephron
present. No cartilage was present. Central cysts with development. These observations support a key role for
transitional-type epithelium were interpreted as calyceal HNF-1b in both b-cell function and during the develop-
structures. The liver did not show the ductal plate malfor- ment of the nephron.
mation described in autosomal recessive polycystic kidney We have demonstrated a reduction in insulin secretion
disease and Meckel syndrome. This appearance was most relative to a glucose load with no elevation in proinsu-
like that of cystic renal dysplasia. lin(s) in our diabetic proband with an HNF-1b mutation.
Chromosome analysis was performed on skin fibro- This supports diabetes resulting from b-cell dysfunction,
blasts and showed a normal karyotype with no evidence rather than insulin resistance, as the primary pathophysi-
of chromosomal deletions or rearrangements. ology, as has been described in patients with HNF-1a
mutations [13, 14]. III-2 does not have diabetes, although
his age precluded a formal OGTT. He is at high risk ofDISCUSSION
developing diabetes in the future. HNF-1a and HNF-1bThe P328L329fsdelCCTCT mutation is the third re-
are known to be expressed in the pancreatic islets, al-ported mutation in the HNF-1b gene associated with
though their role in pancreatic development or geneearly onset, non-insulin-dependent diabetes and renal
regulation at this site is unknown. Pancreatic dysfunctiondysfunction [8, 9]. In the family we describe, the renal
appears to be clinically apparent as a young adult indisease ranges in severity from nonfunctioning cystic kid-
subjects with HNF-1b mutations. This does not excludeneys at 17 weeks of gestation to the presence of a small
that there could be progressive b-cell dysfunction fromnumber of renal cysts and moderate impairment of creat-
inine clearance at age 22 years. We have established that birth, with diabetes developing only once the loss of
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Table 2. Biochemical parameters of II-2 and III-2
Parameter II-2 III-2
Age 22 years 1.6 years
Creatinine clearance mL/min 66 (80–120) 40/1.73 m2 (63–191)a
Creatinine lmol/L 91 (45–120) 69 (35–105)
Urea mmol/L 6.9 (2.1–6.0) 10.2 (1.8–6.0)
Sodium mmol/L 141 (132–144) 143 (132–144)
Potassium mmol/L 4.9 (3.5–5.5) 4.2 (3.5–5.5)
Cholesterol mmol/L 3.5 (3.7–5.2)
Calcium (corrected) mmol/L 2.18 (2.2–2.62) 2.57 (2.17–2.44)
Random glucose mmol/L 6.5
PTH pmol/L 4.5 (0.8–4.8) 6.9 (0.8–4.8)
24-hour urine protein g/24 h 0.15 (0.01–0.14)
Retinol binding protein
g/mmol creatinine 1.3 (1–15)
The age-related reference ranges are shown in parentheses.
aCalculated creatinine clearance from surface area [20]
ported with chronic renal failure and one with protein-
uria [8]. In the second family, the proband and her sister
have an impairment of creatinine clearance and renal
cysts. Their father has dialysis-dependent end-stage renal
failure and renal cysts. The two-year-old son of the pro-
band and the five-year-old daughter of the affected sister
Fig. 3. Response during the first two hours of a 75 g oral glucose have renal dysfunction and cysts. In three members of
tolerance test of plasma glucose (upper graph) and plasma insulin (lower the second reported family, evidence of renal dysfunc-graph; note log scale). Subject II-2 with an HNF-1b mutation is shown
tion and/or renal cysts has preceded the onset of diabetesas a solid line, and the 23 normal control subjects are represented in
dotted lines (mean, coarse dotted line; 12 SD, fine dotted lines.) [9]. In our family, II-2 was noted to have renal cysts at
ultrasound scanning during her first pregnancy before
she presented with diabetes in her second pregnancy.
Renal abnormalities associated with HNF-1b muta-b-cell function is greater than the reserve capacity of the
tions may be detected at an early stage of renal develop-pancreas.
ment. In our family, a fetus of 17-weeks gestation showedOur family does not show the autosomal dominant
no normal nephrogenesis. In an earlier report, fetal ultra-inheritance of diabetes characteristic of MODY because
sound scanning at 27 weeks of gestation revealed renalII-2 had a spontaneous mutation of the HNF-1b gene.
abnormalities [9]. This is a different pattern to the renalThis is the first spontaneous mutation to be described in
dysfunction that may develop with HNF-1a mutationsthe HNF-1b gene. Screening for HNF-1b mutations is
where proteinuria is a manifestation of diabetic nephrop-therefore worthwhile in patients with renal dysfunction
athy occurring later in the course of the disease andand young-onset diabetes even in the absence of a clear
related to glycemic control [17]. However, in II-2, thefamily history of diabetes or renal disease. HNF muta-
short duration of diabetes and absence of frank protein-tions account for approximately 70% of patients with
uria mean that it is unlikely that she had diabetic ne-MODY. The most common cause is HNF-1a mutations
phropathy as the cause of her renal dysfunction, as sug-(65%), with 4% being HNF-4a mutations [1]. It is un-
gested in the first report of a mutation in the HNF-1blikely that HNF-1b accounts for more than 2% of
gene [8]. In the absence of a renal biopsy, it is impossibleMODY, but in view of the limited number of reports,
to exclude diabetic nephropathy completely. Four of theprevalence figures are uncertain [8, 9, 24]. MODY ac-
families we studied would meet the criteria for MODY.counts for only approximately 1 to 2% of subjects with
Many of the subjects will have diabetic nephropathydiabetes in the European Caucasian population [25].
along with other diabetic complications related to long-Two other mutations in the HNF-1b gene have been
term poor control. In the only other family in which therereported: the nonsense mutation R117X [8] and the
is clear evidence of cystic renal disease, the phenotypeframeshift mutation A263fsinsGG [9]. Both mutations
appears more that of adult polycystic kidney diseaseencode truncated proteins (of 176 and 264 amino acids,
and diabetes arising as two coincidental defects. Somerespectively) that have intact dimerization domains but
individuals within the family have early-onset diabeteslack the transactivation domain. In both families, the
but not cystic kidney disease.degree of renal dysfunction in affected members has
been variable. In the first family, two members are re- Renal abnormalities arising early in human kidney
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Fig. 5. Postmortem appearance of 17-week fe-
tus with bilateral enlarged kidneys.
development are consistent with observations in the rat. nephrogenic mesenchyme to differentiate into the epi-
thelium of the kidney tubules. By 15.5-days postcoitum,HNF-1b but not HNF-1a transcripts, detected by in situ
hybridization, are present at 12- to 13-days postcoitum, when HNF-1a transcripts first appear, aggregates of
nephric mesenchyme become more differentiated, ini-as the ureteric bud bulges from the Wolfian duct and
invades the metanephrogenic mesenchyme. This is the tially as a condensed mass and then a vesicular (comma-
shape) stage and finally elongating into an S-shaped tu-early inductory phase of kidney development when sig-
nals from the mesenchyme stimulate branching of the bular structure. The distal extremity of the S-shaped
structure will form the glomerulus and the remainingureteric bud, and the ureteric bud “induces” the meta-
b
Fig. 4. (A) Ultrasound III-2 right kidney. This shows a small, irregular 4 cm kidney containing several cysts (largest 1 cm). (B) Ultrasound III-2
left kidney. This shows a 5.4 cm kidney with a loss of corticomedullary differentiation.
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Fig. 6. Histology of fetal kidney. Absent nephrogenesis with replacement of renal parenchyma by cysts separated by mesenchyme.
segments the proximal and distal convoluted tubules and presence of HNF-1b is unable to compensate for the
deficiency in HNF-1a [16].loop of Henle. HNF-1b transcripts are strongly expressed
This HNF-1b mutation would appear to be a furtherin all the stages of differentiation of the nephric mesen-
example of a mutation in a transcription factor importantchyme and in the ureteric bud. HNF-1a transcripts are
in early nephron development causing human renal dys-only detected in the S-shaped structure. The distal ex-
function. Another example is the PAX2 mutation, whichtremity is negative for both genes. In the newborn rat,
may cause the renal–coloboma syndrome [26]. Renal–kidney nephrogenesis continues until two weeks postpar-
coloboma syndrome is characterized by autosomal domi-tum. Nephrogenesis occurs at the periphery of the kid-
nant inheritance with optic nerve anomalies and thinningney, with differentiated nephrons being displaced to in-
of the retinal epithelium with loss of visual acuity andner parts of the kidney. Only HNF-1b transcripts are
impaired visual fields. There may be associated chronicdetected in the peripheral nephrogenic zone. HNF-1a
renal failure, chronic glomerulonephritis, and/or renaland HNF-1b transcripts are found in the proximal and
hypoplasia. The phenotypes of families with PAX2 muta-
distal convoluted tubules and loop of Henle in the late
tions are variable.
and terminal differentiation zones. HNF-1b alone is de- The severity of the renal dysfunction associated with
tected in the collecting ducts and neither HNF-1b nor HNF-1b mutations is variable, as shown in our family
HNF-1a in the ureter, bladder, and urethra. Therefore, in which the same heterozygous mutation caused a wide
HNF-1b would seem to be important in the early induc- range of severity in renal dysfunction. The mechanisms
tory phase of kidney development, as well as in the later for this are uncertain, and it is not even known if the
stages of cellular differentiation. HNF-1a appears later crucial determinants of phenotype are genetic or envi-
in the postinductory phase and only in cells committed ronmental factors or both. In our family, an additional
to tubular differentiation [12]. Homozygous mice that genetic factor may have been inherited from the father,
lack the HNF-1a gene have features of Fanconi syn- resulting in a more severe phenotype in the children.
Alternatively, there may have been protective genes in-drome with renal proximal tubular dysfunction. The
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hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetesherited by II-2. A further possible explanation is that an
of the young (MODY1). Nature 384:458–460, 1996
environmental effect such as maternal hyperglycemia 7. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset
type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genetduring pregnancy may have been critically important.
17:138–139, 1997This requires further study. Predictions about the renal 8. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cock-
prognosis in subjects with HNF-1b mutations should burn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O,
Kuroki H, Kasahara T, Iwamoto Y, Bell GI: Mutation in hepato-therefore be cautious. In our study, III-2 has an unex-
cyte nuclear factor-1 beta gene (TCF2) associated with MODY.pected degree of hyperparathyroidism for the level of Nat Genet 17:384–385, 1997
9. Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, Horikawarenal function. One explanation would be reduced pro-
Y, Bell GI, Takeuchi T, Takeda J: Frameshift mutation, A263-duction of the active 1,25-dihydroxycholecalciferol in the
fsinsGG, in the hepatocyte nuclear factor-1 beta gene associated
proximal tubule, if there has been an impairment in with diabetes and renal dysfunction. Diabetes 47:1354–1355, 1998
10. Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtreeproximal tubular cell development as a consequence of
GR: HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerisationthe HNF-1b mutation. and homeo domains, but not activation domains, and form hetero-
In conclusion, we have reported a spontaneous muta- dimers in vitro. Genes Dev 5:1042–1056, 1991
11. Rey-Campos J, Chouard T, Yaniv M, Cereghini S: vHNF1 is ation in the HNF-1b gene causing early-onset diabetes
homeoprotein that activates transcription and forms heterodimers
with b-cell dysfunction and renal disease present at an with HNF1. EMBO J 10:1445–1457, 1991
12. Lazzaro D, de Simone V, de Magistris L, Lehtonen E, Corteseearly stage of renal development. HNF-1b would appear
R: LFB1 and LFB3 homeoproteins are sequentially expressed dur-to have a crucial role in the development of the nephron, ing kidney development. Development 114:469–479, 1992
as well as a role in pancreatic function. 13. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Drons-
field MJ, Bain SC, Hattersley AT, Velho G, Froguel P, Bell
GI, Polonsky KS: Altered insulin secretory responses to glucose
ACKNOWLEDGMENTS in diabetic and nondiabetic subjects with mutations in the diabetes
susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503–This work was supported by the British Diabetic Association, the
1510, 1996Northcott Devon Medical Foundation, the Medical Research Council, 14. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelinthe Royal Devon & Exeter NHS Healthcare Trust, the University of L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen
Exeter, DIRECT, PPP Healthcare Trust, The Darlington Trust, and T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas
the Exeter Kidney Unit Development Fund. The authors thank the J, Duyk G, Lander E, Taskinen M-R, Groop L: Characterization
MODY families and their referring physicians who made this study of the MODY3 phenotype: Early-onset diabetes caused by an
possible. The BDA Warren MODY Collection is coordinated by the insulin secretion defect. J Clin Invest 99:582–591, 1997
British Diabetic Association, and we gratefully acknowledge the help 15. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, Kerner W,
of Dr. Moira Murphy and Professor Simon Howell. The technical Menzel S: A low renal threshold for glucose in diabetic patients
assistance of Mr. Martin Goddard and Ms. Diane Jarvis is appreciated. with a mutation in the hepatocyte nuclear factor-1 alpha (HNF-1
alpha) gene. Diabet Med 15:816–820, 1998
Reprint requests to Dr. Andrew Hattersley, Department of Vascular 16. Pontoglio M, Barra J, Hadchouel M, Doyen A, Kress C, Poggi
Bach J, Babinet C, Yaniv M: Hepatocyte nuclear factor 1 inactiva-Medicine and Diabetes Research, School of Postgraduate Medicine
tion results in hepatic dysfunction, phenylketonuria, and renal fan-and Health Sciences, Barrack Road, Exeter, Devon, EX2 5AX, United
coni syndrome. Cell 84:575–585, 1996Kingdom.
17. Velho G, Charpentier G, Vaxillaire M, Froguel P, Boccio V:E-mail: A.T.Hattersley@exeter.ac.uk
Diabetes complications in NIDDM kindreds linked to the MODY3
locus on chromosome 12q. Diabetes Care 19:915–919, 1996
REFERENCES 18. Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S,
Sarelin L, Ha¨ggblom M, Groop L: Chronic diabetic complications
1. Hattersley AT: Maturity-onset diabetes of the young: Clinical in patients with MODY3 diabetes. Diabetologia 41:467–473, 1998
heterogeneity explained by genetic heterogeneity. Diabet Med 19. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H: Insulin response
15:15–24, 1998 to oral glucose load is consistently decreased in established non-
2. Tattersall RB: Mild familial diabetes with dominant inheritance. insulin-dependent diabetes mellitus: The usefulness of decreased
Q J Med 43:339–357, 1974 early insulin response as a predictor of non-insulin-dependent dia-
3. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel betes mellitus. Diabet Med 13(Suppl 6):S109–S119, 1996
MO, Lesage S, Vionnet N, Clement K, Fougerousse F, Tanizawa 20. Clayton BE, Jenkins P, Round JM: Paediatric Chemical Pathol-
ogy. Oxford, Blackwell Scientific Publications, 1980, pp 60–63Y, Weissenbach J, Beckmann JS, Lathrop GM, Passa P, Permutt
21. Kaplan BS, Kaplan P, Kotlus Rosenberg H, Lamothe E, Rosen-MA, Cohen D: Close linkage of glucokinase locus on chromosome
blatt DS: Polycystic kidney diseases in childhood. J Pediatr7p to early-onset non-insulin-dependent diabetes mellitus. Nature
115:867–880, 1989356:162–164, 1992
22. Bernstein J, Kissane JM: Hereditary disorders of the kidney,4. Hattersley AT, Turner RC, Permutt MA, Patel P, Tanizawa
in Perspectives in Paediatric Pathology, edited by Rosenberg H,Y, Chiu KC, O’Rahilly S, Watkins PJ, Wainscoat JS: Linkage
Bolande RP, Chicago, Year Book Medical Publishers, 1973, p 435of type 2 diabetes to the glucokinase gene. Lancet 339:1307–1310,
23. Bernstein J, Brough AJ, McAdams AJ: The renal lesion in syn-1992
dromes of multiple congenital malformations. Birth Defects 10:35–5. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxil-
43, 1974laire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen 24. Beards F, Frayling T, Bulman M, Horikawa Y, Allen L, Apple-
X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori ton M, Bell GI, Ellard S, Hattersley AT: Mutations in hepato-
H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Pedersen cyte nuclear factor 1b are not a common cause of maturity-onset
O, Polonsky KS, Turner RC, Velho G, Chevre J-C, Froguel diabetes of the young in the U.K. Diabetes 47:1152–1154, 1998
P, Bell GI: Mutations in the hepatic nuclear factor 1 alpha gene 25. Hattersley AT: Maturity-onset diabetes of the young. Baillieres
in maturity-onset diabetes of the young (MODY3). Nature Clin Paediatr 4:663–680, 1996
384:455–458, 1996 26. Sanyanusin P, McNoe LA, Sullivan MJ, Weaver RG, Eccles
6. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, MR: Mutation of PAX2 in two siblings with renal-coloboma syn-
Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the drome. Hum Mol Genet 4:2183–2184, 1995
